Phase I and pharmacokinetic study of D-verapamil and doxorubicin

This publication has 14 references indexed in Scilit:

• The activity of verapamil as a resistance modifier in vitro in drug resistant human tumour cell lines is not stereospecific
  Biochemical Pharmacology, 1990
• Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil
  British Journal of Cancer, 1989
• Expression of Multidrug Resistance Gene in Human Cancers
  JNCI Journal of the National Cancer Institute, 1989
• Effect of verapamil on doxorubicin activity and pharmacokinetics in mice bearing resistant and sensitive solid tumors
  Cancer Chemotherapy and Pharmacology, 1988
• Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.
  Journal of Clinical Oncology, 1987
• The effect of verapamil on the pharmacokinetics of adriamycin
  Cancer Chemotherapy and Pharmacology, 1986
• Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells
  Cell, 1986
• The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans
  American Heart Journal, 1985
• Stereoselective first‐pass metabolism of highly cleared drugs: studies of the bioavailability of L‐ and D‐verapamil examined with a stable isotope technique.
  British Journal of Clinical Pharmacology, 1984
• Rapid high-performance liquid chromatographic method for the measurement of verapamil and norverapamil in blood plasma or serum
  Journal of Chromatography A, 1981